- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 233/64 - Amides d'acides carboxyliques ayant des atomes de carbone de groupes carboxamide liés à des atomes de carbone de cycles aromatiques à six chaînons
Détention brevets de la classe C07C 233/64
Brevets de cette classe: 150
Historique des publications depuis 10 ans
|
6
|
9
|
10
|
7
|
13
|
20
|
6
|
6
|
9
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Milliken & Company | 1216 |
10 |
| Syngenta Participations AG | 3029 |
7 |
| King Abdulaziz University | 505 |
7 |
| BASF SE | 20458 |
6 |
| Emory University | 1592 |
5 |
| Eurofarma Laboratorios S.A. | 35 |
5 |
| Universidade Federal do Rio de Janeiro-ufrj | 83 |
5 |
| GE Healthcare AS | 235 |
4 |
| The Wistar Institute of Anatomy and Biology | 436 |
4 |
| Merck Sharp & Dohme Corp. | 2216 |
2 |
| Boehringer Ingelheim International GmbH | 4750 |
2 |
| Kaneka Corporation | 4498 |
2 |
| Abbvie Inc. | 1785 |
2 |
| The Florida International University Board of Trustees | 581 |
2 |
| Mcmaster University | 775 |
2 |
| Shanghai Haiyan Pharmaceutical Technology Co. Ltd | 107 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2844 |
2 |
| The University of British Columbia | 1468 |
2 |
| Yangtze River Pharmaceutical (Group) Co., Ltd. | 142 |
2 |
| Vincere Biosciences, Inc. | 6 |
2 |
| Autres propriétaires | 75 |